Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >

bYoRNA


91370 Verrières-Le-Buisson

Mail: genopole@byorna.bio

CEO: Pascal VIGUIÉ
co-CEO: Thierry ZIEGLER
Web site >

Logo Gene.iO small

#Health & well-being

  • RNA
  • Bioproduction
  • Yeast
  • Rare diseases

Field of activity


ByoRNA is developing a platform for the bioproduction of RNA through fermentation in eukaryotic cells, a paradigm shift from in vitro synthesis.

BACKGROUND
ByoRNA was created in September 2022 by Pascal Viguié, a seasoned entrepreneur, and Thierry Ziegler, a veteran of pharmaceutical bioproduction, with scientific support from Chantal Pichon, a specialist in messenger RNA.

DESCRIPTION OF PRODUCTS / SERVICES / TECHNOLOGY
The technology developed by ByoRNA enables the production of humanized messenger RNA (mRNA) in a traditional bioreactor using a single cell culture. The industrialized process will be less expensive than the current multi-enzyme synthesis, which requires a different cell culture for each enzyme. The mRNA will be used for the development of new gene therapies and cancer vaccines.

CUSTOMER REFERENCES / COLLABORATIONS / HIGHLIGHTS
ByoRNA is a laureate from the Génopole Gene.Io program, and has been selected to be part of the first incubation/investment cohort of Antler Capital in France. In November 2022, we were granted the development license of a disruptive RNA bioproduction patent from a major French research organization.

COLLABORATIONS SOUGHT
We are looking for partnerships with biotech companies in the pre-clinical phase, developing therapies requiring large quantities of RNA (e.g.: rare diseases).

  • FURTHER INFORMATION

    Strengths: large-scale, low-cost RNA production. Experienced and complementary team targeting a fast-growing market.

    Innovation assets: breakthrough technology based on a French patent.

Share
Genopole’s companies

#Health & well-being


In the same field

Vitropep -entreprise genopole

Vitropep

Vitropep developed a unique technology allowing to inject certain peptides without cold chain and with self-administration.

Discover
Exosome Analytics - Entreprise génopolitaine

Exosome Analytics

Exosome Analytics develops techniques for EVs isolation and highly sensitive detection of protein markers on EVs for their application in liquid biopsy.

Discover
Kyron.Bio - Genopole's Company

Kyron.Bio

Kyron.Bio is a biotech company using synthetic biology to produce new therapies with high yield, activity, and stability standards.

Discover
CGenetix - Entreprise génopolitaine

CGenetix

CGenetix, is a medTech start-up developing in vitro medical diagnostic devices for the follow-up of transplant patients.

Discover
EndoGene.Bio - Genopole's Company

EndoGene.Bio

Research & development for an in vitro diagnostic tool for endometriosis

Discover
Exosome Analytics - Entreprise génopolitaine

Exosome Analytics

Exosome Analytics develops techniques for EVs isolation and highly sensitive detection of protein markers on EVs for their application in liquid biopsy.

Discover
Maison M - Startup génopolitaine

Maison M

Personalized and sustainable Cosmetic House inspired by various and unique beauties. The innovative Maison M lipstick delivers any shade customized by its user.

Discover
Cell Environment - Genopole's company

Cell Environment

Cell Environment is a company focusing on DNA damage detection involving unique and repeated sequences such as telomere and centromere sequences.

Discover
Innovhem - Entreprise génopolitaine

Innovhem

Our mission is to improve the management of Red Blood Cell diseases and in particular Sickle Cell Disease

Discover
StemSelect - Entreprise génopolitaine

StemSelect

The aim of StemSelect is to pave the way for a general access to cell therapy. The company develops a rapid isolation method of stem cells derived from one’s own fat tissue.

Discover
Synsight - Genopole's Company

Synsight

Synsight is a company specializing in the discovery and preclinical development of new therapeutic molecules, based on a proprietary, integrated platform, combining artificial intelligence, molecular modeling and a functional experimental screening approach of High-Content Screening (HCS ).

Discover
Sebia - Genopole's Company

Sebia

Design, manufacture and commercialization of in vitro diagnostic systems (instruments and reagents) for medical biology laboratories.

Discover
IntegraGen - Genopole's Company

Integragen

IntegraGen’s mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries.

Discover
Généthon - Genopole's Laboratory

Généthon

Discovery, development and production of innovative therapies for rare genetic diseases, notably neuromuscular diseases.

Discover

Enterome

Enterome develops and commercializes therapies for disorders associated with disruption of the intestinal microbiota.

Discover
Enalees - Genopole's company

Enalees

Enalees conceives, develops and markets next-generation rapid molecular diagnosis tests for veterinarians, and furthermore screening tests for SARS-CoV-2.

Discover
logo abcell Bio - Genopole's Companie

ABCell-Bio

Abcell-bio is a laboratory specializing in the isolation of human hematopoietic stem cells and primary cells derived from perinatal tissue and cord blood.

Discover
Logo Ab Science - Genopole's company

AB Science

Research, development and commercialization of tyrosine kinase inhibitors as targeted therapy for pathologies with unmet medical needs.

Discover
View all >
With the support from
Région île de France